These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1198407)

  • 1. Alterations in the effects of warfarin in dogs by halofenate: an influence upon the kinetics of prothrombin.
    Weintraub M; Griner PF
    Thromb Diath Haemorrh; 1975 Nov; 34(2):445-54. PubMed ID: 1198407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anomalous results of studies on drug interaction in man. II. Halofenate (mk-185) and antipyrine, bishydroxycoumarin, and warfarin.
    Vesell ES; Passananti GT
    Pharmacology; 1975; 13(2):112-27. PubMed ID: 49900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of dextrothyroxine on the kinetics of prothrombin activity: proposed mechanism of the potentiation of warfarin by D-thyroxine.
    Weintraub M; Breckenridge RT; Griner PF
    J Lab Clin Med; 1973 Feb; 81(2):273-9. PubMed ID: 4683426
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies in rats on the mechanism by which 6-mercaptopurine inhibits the anticoagulant effect of warfarin.
    Martini A; Jähnchen E
    J Pharmacol Exp Ther; 1977 Jun; 201(3):547-53. PubMed ID: 864594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of hypoglycemic effect of sulfonylureas by halofenate.
    Jain AK; Ryan JR; McMahon FG
    N Engl J Med; 1975 Dec; 293(25):1283-6. PubMed ID: 171574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hyperlipemia and hyperuricemia with 2-acetamidoethyl-(4-chlorophenyl)-(3-trifluoromethylphenoxy)-acetate (halofenate), a derivative of clofibrate].
    Keller C; Wolfram G; Zöllner N
    Arzneimittelforschung; 1976; 26(12):2221-4. PubMed ID: 798591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of halofenate on triglyceride and uric acid levels, coagulation and platelet behaviour in patients with hyperlipoproteinemia type IV and hyperuricemia (author's transl)].
    Kuntzen O; Hehl FJ; Walter E; Zimmermann R
    Arzneimittelforschung; 1978; 28(12):2349-52. PubMed ID: 227420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
    Black DJ; Kunze KL; Wienkers LC; Gidal BE; Seaton TL; McDonnell ND; Evans JS; Bauwens JE; Trager WF
    Drug Metab Dispos; 1996 Apr; 24(4):422-8. PubMed ID: 8801057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose fluconazole therapy potentiates the hypoprothrombinemic response of warfarin sodium.
    Crussell-Porter LL; Rindone JP; Ford MA; Jaskar DW
    Arch Intern Med; 1993 Jan; 153(1):102-4. PubMed ID: 8422191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions of amitriptyline and nortriptyline with warfarin in the rat.
    Loomis CW; Racz WJ
    Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):41-58. PubMed ID: 7433768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norfloxacin does not alter warfarin's disposition or anticoagulant effect.
    Rocci ML; Vlasses PH; Distlerath LM; Gregg MH; Wheeler SC; Zing W; Bjornsson TD
    J Clin Pharmacol; 1990 Aug; 30(8):728-32. PubMed ID: 2401751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence, magnitude, and time course of the amiodarone-warfarin interaction.
    Kerin NZ; Blevins RD; Goldman L; Faitel K; Rubenfire M
    Arch Intern Med; 1988 Aug; 148(8):1779-81. PubMed ID: 3401099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit.
    Breckenridge AM; Cholerton S; Hart JA; Park BK; Scott AK
    Br J Pharmacol; 1985 Jan; 84(1):81-91. PubMed ID: 3978316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):80-4. PubMed ID: 6491977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of 2-acetoamidoethyl (p-chloro-phenyl) (m-trifluoromethylphenoxy) acetate (halofenate) on hepatic drug metabolism in retired breeder rats.
    Anthony LE; Jones AL
    Proc Soc Exp Biol Med; 1977 Jan; 154(1):142-5. PubMed ID: 402655
    [No Abstract]   [Full Text] [Related]  

  • 17. The stereoselective interaction of warfarin and metronidazole in man.
    O'Reilly RA
    N Engl J Med; 1976 Aug; 295(7):354-7. PubMed ID: 934223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.
    Ganeval D; Fischer AM; Barre J; Pertuiset N; Dautzenberg MD; Jungers P; Houin G
    Clin Nephrol; 1986 Feb; 25(2):75-80. PubMed ID: 3698349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of a new hypolipidemic agent, 2-acetamidoethyl(p-chlorophenyl) (m-trifluoromethylphenoxy)-acetate (halofenate) in the rat, dog, rhesus monkey and man.
    Hucker HB; Grady LT; Michniewicz BM; Stauffer SC; White SE; Maha GE; McMahon FG
    J Pharmacol Exp Ther; 1971 Nov; 179(2):359-71. PubMed ID: 5002483
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of effect of mealtime wine on the hypoprothrombinemia of oral anticoagulants.
    O'Reilly RA
    Am J Med Sci; 1979; 277(2):189-94. PubMed ID: 463946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.